7686.T
The company operates in the Food & Drug Retailing industry, primarily generating revenue through the retail sale of food and drug products.
Business. 7686.T is a food and drug retailer operating within the Consumer Non-Cyclicals sector. The company generates revenue through the sale of products in the food retail and distribution industry. Specific details regarding its operating segments, headquarters location, and primary stock exchange listing are not provided in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
7686.T is a food and drug retailer operating within the Consumer Non-Cyclicals sector. The company generates revenue through the sale of products in the food retail and distribution industry. Specific details regarding its operating segments, headquarters location, and primary stock exchange listing are not provided in the available data.
The company has a market capitalization of 12,024,361,314 JPY, with a market price of 414 JPY per share. The shares outstanding are 29,044,351 for both basic and diluted shares, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in the source documents.
Profitability metrics are not available in the provided data, and no industry-specific preferred metrics are given for comparison. Analyst estimates suggest a mean EPS of 20.40 JPY, compared to the last actual EPS of 18.76 JPY, indicating a potential for improved earnings performance. The mean revenue estimate is 141,000,000,000 JPY, compared to the last actual revenue of 134,514,000,000 JPY, suggesting a projected increase in revenue.
Segment and geographic exposure details are not provided in the available data. The company's growth trajectory is indicated by the projected increase in revenue and the potential for improved earnings, as reflected in the analyst estimates.
Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and no going-concern language in the source documents. The dilution potential is low, as the number of basic and diluted shares is the same. No recent events, such as filings or transcripts, are provided in the available data.
- The company has a market capitalization of 12,024,361,314 JPY and a market price of 414 JPY per share.
- Analyst estimates suggest a potential for improved earnings performance and increased revenue.
- The company's liquidity risk could not be assessed due to missing balance-sheet data.
- The dilution potential is low, as the number of basic and diluted shares is the same.
- No recent events or detailed segment and geographic exposure data are available.
- **margin_outlook_rationale**: The potential for improved earnings is indicated by the analyst estimates showing a mean EPS of 20.40 JPY compared to the last actual EPS of 18.76 JPY.
- **rd_outlook_rationale**: No specific information on research and development outlook is available in the provided data.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 20,40 |
| Revenue | —no estimate | —no estimate | 141,0B JPY |
| Operating income | —no estimate | —no estimate | —no estimate |
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- 7686.T Market data — financials · 2026-05-27
- HitoMile Co Ltd Market data — analyst estimates · 2026-05-27